Hyperlipidemia impaired innate immune response to periodontal pathogen Porphyromonas gingivalis in Apolipoprotein E knockout mice by Lei, Lang et al.
Hyperlipidemia Impaired Innate Immune Response to
Periodontal Pathogen Porphyromonas gingivalis in
Apolipoprotein E Knockout Mice
Lang Lei1., Houxuan Li1., Fuhua Yan2*, Yin Xiao3*
1 School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China, 2 Institute and Hospital of Stomatology, Nanjing University Medical School, Nanjing,
Jiangsu, China, 3 Bone Research Lab, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia
Abstract
A finely-tuned innate immune response plays a pivotal role in protecting host against bacterial invasion during periodontal
disease progression. Hyperlipidemia has been suggested to exacerbate periodontal health condition. However, the
underlying mechanism has not been addressed. In the present study, we investigated the effect of hyperlipidemia on innate
immune responses to periodontal pathogen Porphyromonas gingivalis infection. Apolipoprotein E-deficient and wild-type
mice at the age of 20 weeks were used for the study. Peritoneal macrophages were isolated and subsequently used for the
study of viable P. gingivalis infection. ApoE2/2 mice demonstrated inhibited iNOS production and impaired clearance of P.
gingivalis in vitro and in vivo; furthermore, ApoE2/2 mice displayed disrupted cytokine production pattern in response to P.
gingivalis, with a decreased production of tumor necrosis factor-a, interleukin-6 (IL-6), IL-1b and monocyte chemotactic
protein-1. Microarray data demonstrated that Toll-like receptor (TLR) and NOD-like receptor (NLR) pathway were altered in
ApoE2/2 mice macrophages; further analysis of pattern recognition receptors (PRRs) demonstrated that expression of
triggering receptors on myeloid cells-1 (TREM-1), an amplifier of the TLR and NLR pathway, was decreased in ApoE2/2 mice
macrophages, leading to decreased recruitment of NF-kB onto the promoters of the TNF-a and IL-6. Our data suggest that
in ApoE2/2 mice hyperlipidemia disrupts the expression of PRRs, and cripples the host’s capability to generate sufficient
innate immune response to P. gingivalis, which may facilitate immune evasion, subgingival colonization and establishment
of P. gingivalis in the periodontal niche.
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Introduction
Periodontal disease,a common infection-driven chronic inflam-
matory disease, is characterized by destruction of the supporting
tissues around the tooth. Porphyromonas gingivalis, a gram-negative
oral anaerobe, is implicated as a predominant contributor to
human periodontitis. Within the privileged anatomical niche of
periodontal pocket, P. gingivalis can replicate and destroy
periodontal tissue [1]. The innate immune system uses sentinel
cells (monocytes, neutrophils, macrophages, dendritic cells),
bearing pattern recognition receptors (PRRs), to recognize
common molecular patterns on periodontal bacterial invaders,
generating the immune and inflammatory responses, which leads
to clearance of the bacteria [2].
Hyperlipidemia, resulting from impaired lipid metabolism by
undue intake of cholesterol or genetic deficiency, has been
suggested to exacerbate periodontal parameters in periodontitis
patients in epidemiologic studies [3,4,5]. High-cholesterol food or
fatty acid itself may depress immune function and bactericidal
effect on P. gingivalis in the host [6,7], and feeding animals a high-
cholesterol diet impairs lipid metabolism and enhances periodon-
tal destruction in lipopolysacchride (LPS) induced periodontitis in
rats [8]. However, the underlying mechanism by which hyperlip-
idemia influences periodontal disease progress, especially the
interaction between the innate immune system (including the
PRRs) and the periodontal pathogen remains to be established.
Nearly half of the population above 20 years of age in the
developed countries like USA and one third of the population
above 35 years of age in the developing countries like China have
hyperlipidemia [9,10], whereas nearly half of the Chinese adults
are inflicted with moderate to severe form of periodontal diseases
[11]. Therefore, it is of great importance to understand the
relationship between hyperlipidemia and periodontal disease.
Although it has been demonstrated that periodontal diseases
could influence lipid metabolism in the serum and the blood vessel
[12,13], it is not clear whether and how lipid metabolism anomaly
in the blood may also affect periodontal disease progress.
Apolipoprotein E deficient (ApoE2/2) mice develop severe
hyperlipidemia under normal diet condition [14]. In the present
study, we tested our hypothesis that long term hyperlipidemia
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itself, rather than diet lipid, impaired the host immune response to
periodontal infection in ApoE2/2 mice compared to healthy
C57BL/6 mice. We found that long term hyperlipidemia impaired
the immune response to P. gingivalis challenge by altering PRRs
expression pattern in macrophages, leading an inhibited cytokine
network response and decreased bacterial clearance; therefore,
hyperlipidemia may lead to more severe periodontal bone loss.
Materials and Methods
Bacteria
P. gingivalis 33277 was obtained from the American Type
Culture Collection, and cultured in brain heart infusion (BHI)
broth (Oxoid,UK) supplemented with 5 mg/mL of hemin and
0.5 mg/mL of menadione at 37uC in an anaerobic environment
consisting of 90% N2, 5% CO2 and 5% H2. Bacterial suspensions
were prepared from cultures at their log phase of growth. Bacterial
concentration was evaluated by measuring optical density at
600 nm (OD=1, corresponding to 109 bacteria/mL), and
adjusted to the desired treatment concentration by dilution with
phosphate buffered solution (PBS).
Animals
One hundred six-week-old male C57BL/6 wild type (WT) mice
and ApoE2/2 mice (Jackson Laboratories, BarHarbor, Me, US)
were fed a regular mouse chow diet ad libitum until about 20 wks
of age to experience long term hyperlipidemia. All animal studies
were performed in accordance with the policies of the Institutional
Animal Care and the study has been approved by the Animal
Ethics Committee at Fujian Medical University.
Serum Lipid Level
The serum total cholesterol (TC), triglyceride (TG), low density
lipoprotein cholesterol (LDL-c) and high density lipoprotein
cholesterol (HDL-c) concentration were determined by an
enzymatic method using the protocols provided by the company
(Biosino, Beijing, China). Detection sensitivity for TC, LDL-c,
HDL-c and TG is 0.65 mmol/L, 0.50 mmol/L, 0.13 mmol/L
and 0.15 mmol/L respectively.
Peritoneal Infection
WT and ApoE2/2 mice were infected i.p. with P. gingivalis
33277 (56107 CFU). Peritoneal lavage was performed at indicated
time post-infection. Serial 10-fold dilutions of peritoneal fluid were
plated onto blood agar plates supplemented with hemin/menadi-
one and cultured anaerobically for enumerating recovered
peritoneal CFU. Furthermore, the periondontal lavage was
centrifuged at 3006g at 4uC for 5 min. Then the cellular
components were utilized in Western blot analysis for detecting
iNOS protein, whereas the supernatants were used in both
cytokine antibody array and ELISA to measure cytokine
production.
Cytokine Profile Analysis
Cytokine production in peritoneal fluid supernatants was
analyzed for levels of 62 cytokines by Raybiotech Mouse Cytokine
Antibody Microarray (AAM-CYT- G3, RayBiotech, Narcross,
GA, US) according to the manufacturer’s instructions and as
described earlier [15]. This antibody array detects simultaneously
62 mouse cytokines. Briefly, cytokine array membranes were
blocked in 2 mL of 16blocking buffer for 30 min, and then
incubated with 1 mL of samples at room temperature for 2 h.
Samples were then decanted from each container, and the
membranes were washed three times with 2 mL of l6wash buffer
I, followed by two washes with 2 mL of l6wash buffer II at room
temperature with shaking. Membranes were then incubated in
1:250 diluted biotin-conjugated primary antibodies at room
temperature for 2 h and washed as described above before
incubation in 1:1000 diluted HRP-conjugated streptavidin. After
incubation in HRP-conjugated streptavidin for 60 min, mem-
branes were washed thoroughly and exposed to a peroxide
substrate (detection buffers C and D) for 5 min in the dark before
imaging. Membranes then were imaged using Axon GenePix laser
scanner using cy3 channel. The signal intensities were imported
into RayBioH Analysis Tool. The densities were exported into
Microsoft Excel, and the background intensity was subtracted
prior to analysis. After subtracting background signals and
normalization to positive controls, comparison of signal intensities
for antigen-specific antibody spots between groups were utilized to
determine relative differences in expression levels of each analyte
(i.e., protein detected). Any$2-fold increase or#0.5-fold decrease
in signal intensity for a single analyte between groups were
considered a significant difference in expression, provided that
both sets of signals were well above background (mean
background62 standard deviations).
Macrophage Isolation and Cell Culture
Mouse macrophages were isolated from the peritoneal cavity
upon thioglycolate-induced elicitation [16]. Harvested cells were
subjected to centrifugation on a discontinuous Percoll gradient
(55% and 30%; Sigma, US). Separated macrophages were
resuspended in culture medium (RPMI 1640 supplemented with
10% fetal bovine serum), and cultured at 37uC under 5% CO2
atmosphere. The purity of macrophage preparations (.90%) was
confirmed by flow cytometry using phycoerythrin-labeled anti-F4/
80 (eBioscience, San Diego, CA, US).
Macrophage Intracellular Bacteria Killing Assay
The intracellular P. gingivalis clearance capability of macro-
phages was determined by an antibiotic protection-based survival
assay, as Wang et al described [17]. Briefly, following incubation
of P. gingivalis with macrophages (at a multiplicity of infection
[MOI] of 25:1) for 1.5 h, extracellular nonadherent bacteria were
removed by washing with PBS, whereas extracellular adherent
bacteria were killed by addition of gentamicin (300 mg/mL) and
metronidazole (200 mg/mL) for 1 h. After washing, macrophages
remained to be cultured overnight. Internalized bacteria were
released by lysis of macrophages in sterile distilled water for
20 min. Serial dilutions of the lysates were plated onto blood agar
dishes supplemented with hemin and menadione, and cultured
anaerobically for CFU enumeration.
Phagocytosis
P. gingivalis was labeled with FITC as Hazenbos et al described
[18], then uptake of FITC-labeled P. gingivali was detected by flow
cytometry as Wang et al described [17]. Briefly, primary mouse
macrophages were incubated at 37uC with FITC-labeled P.
gingivalis at a MOI of 25:1 for 30 min. Phagocytosis was stopped by
cooling the incubation plates on ice. Cells were washed to remove
nonadherent bacteria, then extracellular fluorescence (represent-
ing attached but not internalized bacteria) was quenched with
0.2% trypan blue in some groups. Both quenched and
unquenched cells were analyzed by flow cytometry (% positive
cells for FITC-P. gingivalis and mean fluorescence intensity [MFI])
using the FACSCalibur (Becton-Dickinson). Association (repre-
senting both adherence and phagocytosis) or phagocytic indices
were calculated using the formula (% FITC-positive cells6MFI)/
100. When macrophages were pretreated with cytochalasin D to
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block phagocytosis, macrophages that were stimulated with FITC-
labeled P. gingivalis did not show significant fluorescence, which
confirmed that trypan blue effectively quenched extracellular
fluorescence.
Cell Activation and Cytokine Assays
Mouse macrophages were stimulated with P. gingivalis at MOI of
25:1. Cytokines released into culture supernatants were measured
by ELISA according to the protocols of the manufacturers from
the following sources: monocyte chemoattractant protein 1 (MCP-
1), interleukin 1b (IL-1b), IL-6, and IL-12p70 (R&D System,
Minneapolis, MN, US); tumor necrosis factor a (TNF-a), IL-10
(eBioscience, San Diego, CA, US).
Microarray Analysis
Two hours after infection with P. gingivalis (MOI= 25:1), total
RNA of mouse macrophages was extracted using Trizol reagent
(Invitrogen, Carlsbad, California, US) and was further purified by
RNeasy micro kit and RNase-Free DNase Set (QIAGEN,
Germany). Three independent experiments were performed for
each condition. Total RNA was amplified, labeled and purified by
using Affymetrix GeneChip 39IVT Express Kit to obtain biotin
labeled cRNA. Following array hybridization, slides (Affymetrix,
Santa Clara, CA, US) were scanned by GeneChip Scanner 3000
and Command Console Software 3.1 (Affymetrix, US). Differen-
tially expressed genes showing a statistical significance (p,0.05,
one way analysis of variance) and $2-fold change between
ApoE2/2 and the corresponding WT mice were further analyzed
using SBC analysis system (Biochip, Shanghai,China): gene
ontology (GO) analysis was applied to organize genes into
hierarchical categories on the basis of cellular component,
biological process and molecular function; enrichment pathway
analysis (Kegg database) was implemented to uncover the major
perturbed pathways. Complete microarray data have been
deposited in the Gene Expression Omnibus public database
(accession number GSE42061; http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE42061).
Quantitative Real Time PCR (qPCR)
Total RNA was isolated from the cells using Trizol reagent.
One microgram of total RNA was reverse-transcribed using
Superscript II (Invitrogen, USA). Real-time quantitative PCR
reactions were set up in triplicate using the SYBRH Premix Ex
TaqTM II (Takara, Japan) and run on a 7900 HT Sequence
Detection System (ABI, USA). All of the gene expression levels
were normalized to the internal standard gene, GAPDH.
Western Blot
The cellular components in peritoneal fluid were collected after
centrifugation, then washed in Dulbecco’s phosphate-buffered
saline (D-PBS) twice; for in vitro study, macrophages were
harvested after trypsin-EDTA treatment, and rinsed with D-PBS
for three times. Cytoplasmic protein was extracted using NE-PER
nuclear and cytoplasmic extraction reagents and Halt protease
inhibitor cocktails (ThermoScientific, Rockford, IL, US) according
to the manufacturer’s protocol. Protein concentration was
determined by a Bradford protein assay using BSA for standard-
ization, and the cytoplasmic extracts were fractionated on 10%
SDS–PAGE gels, transferred to a nitrocellulose membrane and
incubated overnight with rabbit polyclonal iNOS primary
antibodies (dilutions 1:500) (Abcam, Cambridge, MA, US),
followed by incubation with horseradish peroxidase (HRP)-
conjugated goat anti-rabbit secondary antibody (1:5, 000) (Gene-
script, Piscataway, NJ, US). A 1:3,000 dilution of GAPDH rabbit
polyclonal antibody (Genescript, USA) was used as a loading
control. Bands were visualized by enhanced chemiluminescence
(ECL) method. X-ray films were scanned and saved as grayscale
JPEG files. The level of expression of proteins was analyzed by
using the Image J software (National Institutes of Health, US),
which can calculate area and pixel value statistics of user-defined
selections. Each band was normalized to GAPDH. Each sample
was tested in duplicate, and western blots were repeated three
times.
Flow Cytometry
Following blocking non-specific Fc receptor binding by anti-
mouse CD16/32 antibody (eBioscience, US), mouse macrophages
were incubated with phycoerythin (PE) labeled specific monoclo-
nal antibodies (mAbs) or Ig isotype controls in PBS with 1% (w/v)
BSA and 0.05% sodium azide (FACs buffer, eBioscience,US) on
ice. Subsequently, the cells were washed, and analyzed by
FACSCalibur(Becton-Dickinson). Mouse-specific mAbs to Toll-
like receptors 22 (TLR-2) and TLR-4 were from eBioscience and
mAb to triggering receptors expressed on myeloid cells-1 (TREM-
1) was from R&D Systems.
Chromatin Immunoprecipitation Assays
Mouse macrophages (16107cells per sample) were stimulated,
washed with PBS, and fixed with 1% formaldehyde for 10 min at
room temperature. Formaldehyde fixation was stopped with the
addition of 1.25 M glycine. Sonicated chromatins were then
immunoprecipitated (IP) with anti-p65 (Cell signaling Tech, US)
or with control IgG Abs coupled to microbeads. DNAs from each
sample (input or IP) were isolated by elusion, reverse cross-linking
and proteinase K treatment. The DNA was then used as template
to perform PCR amplification of the regions containing the
proximal nuclear factor-kB (NF-kB) site in the promoters of TNF-
a, IL-6 and IL-10.
Statistical Analysis
Data were represented as the mean 6 standard deviation (SD).
Mean values between the groups were compared using analysis of
variance (ANOVA). Differences were considered significant when
P,0.05.
Results
Metabolic Characteristics of Experimental Animals
ApoE2/2 mice weighed less than WT mice above 12 wks of
age, and blood glucose level in ApoE2/2 mice was not
significantly different from WT mice. ApoE2/2 mice showed
significantly increased LDL-c levels in blood at 10 and 20 weeks,
whereas serum triglyceride was not significantly different (Figure 1).
Impaired Clearance of P. gingivalis in Hyperlipidemic
Mice was Parallel with the Reduced iNOS Production
Based on antibiotic protection-based intracellular killing assay,
we found that macrophages from hyperlipidemic ApoE2/2 mice
showed a decreased tendency to internalize P. gingivalis after
1.5 h incubation (P.0.05), whereas intracellular capability to
remove P. gingivalis was impaired in macrophages from ApoE2/
2 mice in vitro (figure 2A and 2B). Such impaired clearance in
ApoE2/2 mice was confirmed in the peritonitis model in vivo
(figure 2C).
In order to explore the changes in phagocytosis capability in
macrophage, we utilized flow cytometry to measure the phago-
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cytosis of FITC-labled P. gingivalis, and observed that macrophages
from ApoE2/2 mice displayed similar binding and internalizing
capability (figure 2D).
One of the fastest and most effective defense mechanisms for
macrophages to clear invading bacteria is production of the free
radical NO, which is mediated by the expression of inducible
NO synthase (iNOS) [19]. Mice lacking iNOS demonstrated
impaired killing of P. gingivalis and increased periodontal tissue
damage upon P. gingivalis challenge [20,21]. To investigate the
cause of impaired clearance of P. gingivalis in ApoE2/2 mice, we
analyzed the expression of iNOS. iNOS production was
significantly decreased in the peritonitis model in ApoE2/2
mice when compared to WT mice (figure 2E). Macrophages
from ApoE2/2 mice displayed severe disruption of iNOS
expression at both the protein and mRNA levels after P.
gingivalis infection (figure 2F-i, ii).
Depressed Cytokine Production during P. gingivalis
Infection in ApoE2/2 Mice
To further investigate the cause of impaired clearance of P.
gingivalis in ApoE2/2mice, we explored the cytokine profile during
P. gingivalis infection. Six hours after peritoneal infection, we
observed that 23 cytokines, including TNF-a, IL-2, IL-4 and
interferon c, were decreased in peritoneal fluid, whereas only 5
cytokines such as leptin, macrophage inflammatory protein-1a
(MIP-1a) and platelet factor 4 (PF4) were increased in ApoE2/2
mice when compared to WT mice using mice cytokine arrays
(figure 3A–C).
Cytokine production pattern was also determined by ELISA
at 0 h to 24 h after bacterial periotoneal infection. Significantly
less induction of pro-inflammatory cytokines, TNF-a, IL-6, IL-
1b and MCP-1, was found at various time post-infection in
ApoE2/2 mice; whereas anti-inflammatory cytokine IL-10 was
not affected, and IL-12 production was not detectable during
infection (figure 3D–I). Similarly significantly blunt cytokine
Figure 1. Metabolic characteristics of experimental animals. Six-week-old wild type (WT) and ApoE2/2 C57BL/6 mice were fed a normal chow
diet for 14 weeks. Body mass (A), blood glucose (B) and serum lipid levels (C) were measured (n = 5). *, P,0.05.
doi:10.1371/journal.pone.0071849.g001
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production was also found in P. gingivalis infected mice
macrophages in vitro (figure 4A–F).
To further clarify whether the decreased cytokine production in
ApoE2/2 mice was due to long term hyperlipidemia or the
disruption of ApoE gene expression itself, we further analyzed
cytokine production in ApoE2/2 and WT mice at the age of 6 wks
in peritoneal infection model. In contrast to an impaired cytokine
production pattern in ApoE2/2 mice at 20 wks of age, a modestly
but significantly increased cytokine production pattern was found
Figure 2. Impaired clearance of P. gingivalis by inhibiting iNOS induction in ApoE 2/2 mice. A and B, in vitro studies: peritoneal
macrophages from wild type (WT) and ApoE 2/2 mice were infected with P. gingivalis (MOI = 25:1) and CFU of internalized bacteria were determined
at 1.5 and 15 h after infection. C, in vivo studies: mice were infected i.p. with P. gingivalis (56107). Serial dilutions of peritoneal fluid were plated for
anaerobic growth and enumeration of recovered peritoneal CFU. D, peritoneal macrophages were incubated with FITC-labeled P. gingivalis
(MOI = 25:1) for 30 min. Association (i.e., representing both adherence and phagocytosis) or phagocytic indices were determined by flow cytometry,
as described in Materials & Methods, using the following formula: (% positive cells for FITC-P. gingivalis6MFI)/100. E, 24 h after peritoneal infection,
the induction of iNOS was determined by Western blot using the cellular components of the peritoneal fluid after centrifugation, data were
normalized to GAPDH. F, mouse macrophages were infected with P. gingivalis, and iNOS production was determined by Western blot 24 h post
infection (i), and iNOS mRNA was determined by qPCR 2 h post infection (ii). Results were means 6SD (n= 3) and were confirmed in repeated
experiments. *, P,0.05.
doi:10.1371/journal.pone.0071849.g002
Hyperlipidemia Impairs Innate Immune Responses
PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e71849
Hyperlipidemia Impairs Innate Immune Responses
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e71849
in peritoneal stimulation test in ApoE2/2 mice at 6 wks of age
using ELISA (not depicted).
Disrupted Gene Expression Profile after P. gingivalis
Infection in ApoE2/2 Mice Macrophages
A full genome microarray was utilized to investigate global
gene transcription following P. gingivalis infection in macrophag-
es, showing that mRNA transcription was inhibited in ApoE2/2
mouse macrophages. A hierarchical clustering algorithm was
used to group qualifiers with similar patterns of expression. A
heat map of genes of fold change of .5.0 was shown in
figure 5A. 353 genes were up-regulated and 465 genes were
down-regulated in ApoE2/2 control when compared to WT
control; whereas 148 genes were up-regulated and 236 genes
were down-regulated in P. gingivalis infected ApoE2/2 macro-
phages (figure 5B). We then further investigated the logical
relations between the two comparisons, 130 genes were
differentially expressed in both untreated and stimulated
macrophages (figure 5C); furthermore, among such 130 genes,
101 genes were down-regulated and 19 were up-regulated in
both untreated and stimulated macrophages (figure 5D).
To gain insights into the mechanism of disrupted macrophage
response to live P. gingivalis, we focused on differential expression
genes in P. gingivalis infected macrophages utilizing gene
ontology and pathway analysis. We categorized these genes as
down-regulated genes (236 genes) and up-regulated genes (148
genes). In Biological Process analysis, the up-regulated genes are
involved in biological adhesion; whereas down-regulated genes
take part in seven biological processes majorly involved in
bacteria infection such as cell killing, immune system process
and response to stimulus (Table 1). In enrichment pathway
analysis (Kegg), the up-regulated genes are involved in
extracellular matrix-receptor interaction and p53 signaling
pathway; the down-regulated genes are involved in pathways
such as cytokine and cytokine receptor interaction, NOD-like
receptor (NLR) and Toll-like receptor (TLR) pathway (Table 2).
Gene Regulation was Confirmed by qPCR
The microarray results pointed to an inhibited gene response
to viable P. gingivalis. In follow-on studies, we selected genes that
are potentially implicated in inflammatory response to P.
gingivalis: interleukin-1 receptor-associated kinase 1 binding protein 1
Figure 3. Inhibited cytokine production in ApoE2/2 mice in vivo. Wild type (WT) and ApoE2/2 mice were infected i.p. with P. gingivalis
(56107). Peritoneal fluid of 6 h post infection was subjected to cytokine antibody array. Each cytokine is represented by duplicate spots (A). The
cytokine array image represented results of three independent experiments (B). Cytokines with fold change .2.0 and P,0.05 was shown (C). TNF-a,
IL-6, IL-1b, MCP-1, IL-12 and IL-10 levels at 0 h,24 h was determined by ELISA (D-I) (mean6 SD; n = 3; representative of duplicate independent tests).
*, P,0.05.
doi:10.1371/journal.pone.0071849.g003
Figure 4. Inhibited cytokine production in ApoE2/2mice macrophages. Macrophages from wild type (WT) and ApoE2/2mice were exposed
to live P. gingivalis (MOI = 25:1). TNF-a, IL-6, IL-1b, MCP-1, IL-12 and IL-10 in culture supernatants were analyzed by ELISA (mean 6 SD; n= 3). *,
P,0.05.
doi:10.1371/journal.pone.0071849.g004
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(Irak1bp1), signal transducer and activator of transcription 1 (Stat1),
Tnfa, IL6, IL12a, MCP1. qPCR results confirmed gene
microarray efficiency. For example, Irak1bp1, an inhibitor in
TLR pathway, was down-regulated by 1.68 fold in microarray
analysis and 1.86 fold in qPCR in untreated macrophages, and
by 39.89 and 55.98 fold respectively in P. gingivalis infected
macrophages (Table 3).
Different Pattern Recognition Receptors (PRRs)
Expression Pattern in ApoE2/2 Mice
Following the clue that TLR and NLR pathway were affected
in ApoE2/2 mice, we further analyzed the PRRs expression. As
shown in figure 6A, transcription of TLR-2, -4, triggering receptors
expressed on myelod cells -1 (TREM-1), TREM-3 and CD14 was
decreased in untreated macrophages of ApoE2/2 mice, whereas
only TREM-1 mRNA was significantly decreased in P. gingivalis
infected macrophages in ApoE2/2 mice. TLR-2 protein
expression was not affected in both the untreated and
stimulated macrophages, while TREM-1 expression was signif-
icantly decreased in ApoE2/2 mice after bacteria stimulation
(figure 6B). To test the effect of TREM-1 inhibition on immune
response, we blocked TREM-1 with LP-17 peptide 2 h before
stimulation with P. gingivalis, and TREM-1 blockage significantly
inhibited TNF-a and IL-6 production upon P. gingivalis infection
at 6 h in WT mice macrophages (figure 6C). Furthermore,
macrophages from WT mice treated by LP-17 peptide displayed
Figure 5. Disrupted gene profile in ApoE2/2 mice macrophages. Macrophages from wild type (WT) and ApoE2/2 mice were exposed to live
P. gingivalis (MOI = 25:1) for 2 h. Heat map of hierarchical clustering was utilized to reveal gene profiles; shown were qualified genes with fold change
of .5.0 (P,0.05) between any groups (A). Red indicated up-regulation, whereas green indicated down-regulation, and black indicated no change.
Differentially expressed genes in control and bacteria infected macrophages were categorized as up-regulated and down-regulated (B), then a Venn
diagram was utilized to explore the logical relation between the difference expression genes(C), showing 130 genes were affected by hyperlipidemia
in both the untreated and infected macrophages. Further analysis demonstrated 101 genes were down-regulated in the 130 genes (D).
doi:10.1371/journal.pone.0071849.g005
Table 1. Biological process affected by hyperlipidemia in P. gingivalis infected macrophages.
GOId Name Hits1 Percent2 Enrichment test p-value3
Up-regulated
GO:0022610 biological adhesion 10 1.62% 0.0098
Down-regulated
GO: 0008150 Cell killing 5 11.63% 2.00E-04
GO: 0002376 immune system process 41 5.07% 0
GO: 0050896 response to stimulus 53 2.39% 0
GO: 0051704 multi-organism process 8 2.68% 1.15E-02
GO: 0048518 positive regulation of biological process 21 1.66% 0.0325
GO:0048518 negative regulation of biological process 19 1.65% 4.34E-02
1Total count of difference expression genes.
2The proportion of total count versus the number of genes in the biological process.
3Only the biological process with p-value ,0.05 were shown.
Only biological processes that are related to innate immune response to bacterial infection were shown.
doi:10.1371/journal.pone.0071849.t001
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less production of cytokine when compared to macrophages
from ApoE2/2 mice.
Less p65 Binding to Gene Promoters after Decreased
TREM-1 Expression
As TREM-1 is an amplifier of both the TLR and NLR
pathway, down-regulation of TREM-1 may lead to inadequate
signal transduction upon P. gingivalis infection. To further
characterize its effect on the innate immune response to bacteria
invasion, we focused on the transcriptional factor NF-kB, which
plays a key role in regulating the immune response to infection.
We further evaluated the capability of NF-kB p65 subunit’s
binding ability to DNA at TNF-a, IL-6 promoter (classic pro-
inflammatory locus) and IL-10 promoter (anti-inflammatory
locus). Recruitment of p65 to all 3 promoters in macrophages
from ApoE2/2 mice at 15 min was decreased in comparison with
WT mice (Figure 7). Although no difference was observed in the
recruitment of NF-kB to gene promoters at 30 min between
ApoE2/2 mice and WT mice macrophages, binding to kB sites in
ApoE2/2 mice macrophages at 30 min was still less than that in
WT mice macrophages at 15 min.
Discussion
In normal mice, a well-orchestrated cytokine network maintains
a finely-tuned response to bacterial challenge. Cytokines such as
TNF-a and IL-1b that are considered harmful to periodontal
tissue in chronic inflammation play important roles in the control
of pathogen infection in the acute inflammation [22]. The
principal finding of the present study is that hyperlipidemia, a
kind of metabolic anomaly accompanying many obesity subjects,
disrupts host capability to clear periodontal pathogen P. gingivalis,
as a result of impaired capability to mount sufficient immune
response to P. gingivalis. To our knowledge, this is the first report
that systematically investigated the potential mechanisms by which
hyperlipidemia interferes with host’s normal innate response to
periodontal bacterial infection.
Hyperlipidemia may directly influence disease induction and
indirectly modulate immune responses [23]. Lipoproteins can bind
LPS and decrease LPS-stimulated cytokine production [24];
therefore, the inhibited inflammatory response in our study may
partly be attributed to the elevated low density lipoprotein in the
circulation system. In the present study, we found that the ApoE2/
2 mice failed to generate a robust immune response. Congruent
with our results, similar observation was also made during Klebsiella
pneumoniae and Leishmania major infection [23,25]. As ApoE itself has
an immunoinhibitory effect on inflammation [26], animals
deficient in ApoE at an early age exhibit increased cytokine
production in response to Listeria monocytogenes [27], Mycobacterium
tuberculosis [28],Klebsiella pneumoniae [29], and display inhibited type
I inflammatory response to E. coli LPS, a classical TLR4 agonist, in
vivo [30].
In contrast to the impaired cytokine production in ApoE2/2
mice at 20 wks of age, a slightly increased cytokine release to P.
gingivalis was observed in vivo in ApoE2/2 mice at 6 wks of age.
Therefore, the inhibited immune response in ApoE2/2 mice at
20 wks of age can be attributed to long term hyperlipidemia,
which overcomes the effects of ApoE deficiency, leading to
decreased cytokine release and iNOS production. Furthermore,
iNOS deficiency may impair host’s ability to kill P. gingivalis and
aggravate soft tissue damage and alveolar bone loss [20,21,31].
Our study is congruent with the study of Shamshiev et al [32],
Table 2. The list of pathway category (Kegg) in difference
expression genes in P. gingivalis infected macrophages.
Kegg Pathway Name Hits Percent
Enrichment
test p-value
Up-regulated
ECM-receptor interaction 3 3.57% 7.0E-4
p53 signaling pathway 2 2.63% 0.0105
Down-regulated
Antigen processing and presentation 3 2.88% 0.0047
Chemokine signaling pathway 15 7.39% 0.0
Cytokine-cytokine receptor interaction 23 8.49% 0.0
Cytosolic DNA-sensing pathway 5 8.62% 0.0
ECM-receptor interaction 2 2.38% 0.0297
Endocytosis 4 1.67% 0.0074
JAK-STAT signaling pathway 10 6.25% 0.0
Natural killer cell mediated cytoxicity 7 4.35% 0.0
NOD-like receptor signaling pathway 5 7.69% 0.0
p53 signaling pathway 2 2.63% 0.0248
RIG-I-like receptor signaling pathway 6 8.75% 0.0
T cell receptor signaling pathway 3 2.27% 0.0088
TGF-beta signaling pathway 4 4.35% 2.0E-04
Toll-like receptor signaling pathway 8 7.69% 0.0
Only pathways correlated to innate response to bacterial infection were shown.
doi:10.1371/journal.pone.0071849.t002
Table 3. qPCR validation for selected genes affected by hyperlipidemia.
Gene symbol Full name ApoE(blank)vs C57(blank) ApoE(Pg)vs C57(Pg)
Microarray qPCR Microarray qPCR
Stat1 signal transducer and activator
of transcription 1
23.03 22.99 22.08 21.69
Irak1bp1 interleukin-1 receptor-associated
kinase 1 binding protein 1
21.68 21.86 239.89 255.98
Tnfa tumor necrosis factor a 2.29 22.18 21.25 21.23
Il6 interleukin 6 1.07 1.08 22.14 23.78
Il12a interleukin 12A 22.08 22.45 23.09 22.11
Mcp1 monocyte chemotactic protein-1 23.09 21.88 22.08 23.04
doi:10.1371/journal.pone.0071849.t003
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showing that dyslipidemia inhibits TLR induced activation of
CD8a- dendritic cells in ApoE2/2 mice in aged mice (20–30 wks-
age), rather than young mice (5 wk).
In agreement with the inhibited cytokine production in ApoE2/
2 mice, microarray data showed that overall gene response in
ApoE2/2 mice was inhibited, and biological processes related to
innate immune response such as cell killing, immune system process,
response to stimulus, became impaired. Such gene expression profile
would alter the clearance of P. gingivalis in macrophages in vitro and
in vivo. To further discover the mechanism of hyperlipidemia
interfering with the innate response, pathway analysis was
conducted, showing that TLR and NLR pathway was influenced
by hyperlipidemia.
Recognition of invasive pathogens by immune cells relies on
their capacity to detect microbial- or pathogen-associated molec-
ular patterns (PAMPs) [19]. This process involves the coordinated
actions of different membrane-associated or intracellular pattern-
recognition molecules, including TLRs and NLRs [33]. Ligand-
activated receptors trigger the mitogen-activated protein kinases
(MAPKs), NF-kB, and interferon-related factor (IRF) signal
transduction pathways that induce the transcription and produc-
tion of immune genes, including cytokines that are critical for the
activation of innate immunity [34].
Following the clue in microarray results, we further demon-
strated that although TLR-1, -2, -4 and -6, NOD-1 and -2
expressions upon P. gingivalis challenge was not affected, whereas
TREM-1 became significantly inhibited in ApoE2/2 mice. In
addition, in the present study, blockage of TREM-1 by LP-17
peptide significantly inhibited IL-6 and TNF-a production in
response to P. gingivalis in macrophages. As TREM-1 is an
amplifier of both the TLR and NLR signal transduction pathway
[35,36], an inhibited TREM-1 expression may be a potential
cause leading to decreased inflammatory signal transduction and
cytokine release upon P. gingivalis infection. Such effect was
confirmed by the decreased recruitment of NF-kB onto the
promoters of the pro-inflammatory TNF-a and IL-6, and the anti-
inflammatory IL-10. Although we observed an inhibited TREM-1
expression in ApoE2/2 mice macrophages, caution is still required
for the result explanation. Over-expression of TREM-1 in
ApoE2/2 macrophages would further shed insight into the
contributory role of TREM-1 in the disrupted cytokine production
in ApoE2/2 mice.
Understanding kinetic properties of NF-kB interaction with its
target genes, i.e. the binding and unbinding, may help us
understand the inflammatory response to P. gingivalis. After
degradation of their cytoplasmic inhibitors (IkBs), NF-kB dimers
translocate to the nucleus and bind to thousands of 9–10 nt kB
sites dispersed in the genome [37,38], generating complexes with a
half-life of 45 min [39]. As promoter-bound NF-kB is in dynamic
equilibrium with nucleoplasmic dimers, promoter occupancy and
transcriptional activity oscillate synchronously with nucleoplasmic
NF-kB [40]. In addition to its ability to bind to NF-kB in cytosol,
IkBa can also dissociate NF-kB from DNA and export it to the
cytosol [41]. In our experiment, we observed that binding of NF-
Figure 6. Different pattern recognition receptors (PRRs) expression between wild type (WT) and ApoE2/2 mice macrophages. Mice
peritoneal macrophages were infected with P. gingivalis (MOI = 25:1) for 2 h, then mRNA of PRRs related to TLR and NLR pathway were determined by
qPCR (A). TLR-2 and TREM-1 expression were confirmed by flow cytometry (B and C), showing significantly inhibited expression of TREM-1 in ApoE2/2
mice macrophages. Blockage of TREM-1 with LP-17 peptide pretreatment decreased TNF-a and IL-6 production significantly at 6 h after P. gingivalis
infection in peritoneal macrophages. (n = 3). *, P,0.05.
doi:10.1371/journal.pone.0071849.g006
Figure 7. Inhibited recruitment of NF-kB to cytokine promoters in ApoE2/2 mice macrophages. Peritoneal macrophages from wild type
(WT) and ApoE2/2mice were treated with live P. gingivalis (MOI = 100:1) for 15 min and 30 min. NF-kB p65 polyclonal antibody precipitated DNA was
quantified by real time PCR, and the results were expressed as percentage of ChiP DNA to input DNA. *, P,0.05. (n = 3).
doi:10.1371/journal.pone.0071849.g007
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kB in ApoE2/2 mice macrophages at 30 min was similar to that in
WT mice at 30 min, but it was still less than that in WT mice at
15 min. Therefore, NF-kB in ApoE2/2 mice macrophages
demonstrated a later and less competent binding to its promoters,
leading to the decreased production of IL-1b, IL-6, TNF-a, MCP-
1 both in vivo and in vitro.
Activation of monocytes by TLRs stimulants, such as LPS,
results in the rapid production of proinflammatory cytokines,
including TNF-a, IL-1b, and IL-6, followed later by the secretion
of the anti-inflammatory IL-10. However, in our study, IL-10
production in ApoE2/2 mice was not altered in vivo and in vitro,
which was inconsistent with the decreased recruitment of NF-kB
to IL-10 gene promoters. As both NF-kB and MAPK signal
pathways, including ERK, JNK, and p38, are involved in the
classical LPS-induced IL-10 expression [42,43], further explora-
tion on MAPK pathway might unravel the possible role of NF-kB
binding to the IL-10 promoter.
Although we observed an inhibited innate immune response
and TREM-1 expression in hyperlipidemic ApoE2/2 mice, the
possible mechanism by which hyperlipidemia influences PRRs has
not been fully understood. Macrophages express a host of
receptors, such as CD36 and scavenger receptor A, which bind
and internalize modified forms of LDL. Thus serum lipid may be
incorporated into cell membranes and cytoplasm, altering immune
response to PAMPs. Indeed, patients with hyperlipidemia
abnormities displayed altered lipid composition of the cell
membrane and an increased cholesterol contents in cytoplasm in
erythrocytes and lymphocytes [44,45,46,47]. Furthermore, mac-
rophages from ApoE2/2 mice showed 3-fold higher membrane
cholesterol compared with wild-type macrophages [48].
Subtle changes in the lipid composition of the plasma
membrane, particularly the cholesterol content, may result in
the modification on lipid rafts, which provide spatial organization
for transmembrane proteins and act as signaling platforms
responsible for coordinating outside-in and inside-out signal
transduction [49]. Toll-like receptors (TLR) and interleukin
receptors are found within the lipid rafts of cells treated with
pro-inflammatory LPS [50,51,52]. Therefore, alteration in lipid
contents in circulation system may influence cholesterol compo-
Figure 8. Proposed mechanism for impaired host innate immune response to viable P. gingivalis infection by hyperlipidemia in
ApoE2/2 mice. Increased blood lipid would be incorporated into cell membrane and intracellular components of macrophages, leading to the
decreased TREM-1 expression upon P. gingivalis infection. Reduced TREM-1 activation resulted in inadequate signal transduction, less p65 nuclear
translocation and binding to gene promoters region at DNA; therefore, innate immune responses including iNOS production and release of cytokines,
such as TNF-a, IL-6 and MCP-1, were disrupted in the hyperlipidemic host. LDL, low density lipoprotein; TREM-1, triggering receptors expressed on
myeloid cells-1; PRRs, pattern recognition receptors, TLR, Toll-like receptors; NLR, NOD-like receptors; NF-kB, nuclear factor kB; IkB, inhibitory kB; IKK,
IkB kinase complex; iNOS, inducible nitric oxide synthase; IL-6, interleukin 6; MCP-1, monocyte chemoattractant protein 1; TNF-a, tumor necrosis
factor a.
doi:10.1371/journal.pone.0071849.g008
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sition in cell membrane and affect lipid rafts dynamics, leading to
altered inflammatory response to bacteria infection.
P. gingivilis may exploit various receptors in cell membrane to
facilitate its invasion, such as TLR2, CD14, CXC-chemokine
receptor 4 (CXCR4), complement receptor 3 (CD11b/CD18)
[17,53,54,55]. In our study, macrophages from ApoE2/2 mice
showed inhibited transcription of TLR2, TREM-1, TREM-3, and
CD14 in quiescent state, whereas only TREM-1 expression was
influenced by hyperlipidemia in bacteria stimulated macrophages.
In addition to membrane receptors, P. gingivalis utilizes lipid rafts
as signaling and entry platforms [56]. P. gingivalis colocalizes with
lipid rafts in a cholesterol-dependent way, depletion of cellular
cholesterol using methyl-beta-cyclodextrin resulted in about 50%
inhibition of P. gingivalis uptake, and this effect was reversed by
cholesterol reconstitution [56]. Macrophages from ApoE2/2 mice
show higher membrane cholesterol than wild-type macrophages
[48]. Therefore, an increased internalization might be expected in
macrophages from ApoE2/2 mice. In contrast, we failed to
observe changes in phagocytosis in macrophages. Possible roles of
TREM-1 in the inside-out mechanism of P. gingivalis need to be
explored further.
Consistent with Bostanci et al [57], we observed that TREM-1
takes part in the immune response to P. gingivalis in mice
macrophages. Following stimulation by LPS in vitro and in vivo,
monocytes secrete a soluble form of TREM-1 (sTREM-1) [58].
sTREM-1 has been found to correlate with inflammatory disease,
such as sepsis [59,60], relapsing polychondritis [61] and inflam-
matory bowel diseases [62]. Elevated oral and systemic levels of
soluble TREM-1 has been found in periodontitis [63,64].
Therefore, monitoring changes in sTREM-1 level would help
understand inflammation and immune response in the periodontal
niche.
The possible mechanism by which hyperlipidemia impairs
innate immune responses to viable P. gingivalis infection has been
illustrated and summarized in figure 8. Briefly, increased serum
lipid would alter the cholesterol component in the cell membrane
and cytoplasm of macrophages, which might further affect PRR
expression on the cell membrane upon P. gingivalis challenge.
Disrupted activation of TREM-1, a kind of PRRs amplifying the
TLR transduction pathway, could lead to inhibited p65 nuclear
translocation and binding to gene promoters region. Consequent-
ly, innate immune responses including iNOS production and
cytokines release, such as TNF-a, IL-6 and MCP-1, might be
suppressed in the hyperlipidemic host.
Given that chronic periodontitis is characterized by alternate
periods of exacerbation and quiescence [65], the impaired
TREM-1 expression and the inhibited innate immune response
would have a significant influence on the periodontal disease
progress. This inability to mount a sufficient inflammatory
response may lead to inadequate elimination of the bacteria,
which would in turn grow and proliferate in the periodontal niche,
and cause more severe periodontal damage.
In conclusion, we have shown that hyperlipidemia inhibits
inflammatory response in macrophages, which in turn cripples
host’s capability to remove the bacterial infection. These findings
suggest that hyperlipidemia can predispose the host to oral
infection, by impairing proper immune response to bacteria
challenge.
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